$ATML Atmel Corp (ATML) Overall Average: 16% Buy. Thursday,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$ATML Overall Average: 16% Buy. $STLD $AMSC $MYL

Atmel Corp (ATML) Buy - Hold - Sell - Overall Opinion

ATML Last Price: 7.91
Current Change: -0.01 (-0.13%)

Composite Indicators - Signal
TrendSpotter - Sell

Short Term Indicators
7 Day Average Directional Indicator - Sell
10 - 8 Day Moving Average Hilo Channel- Buy
20 Day Moving Average vs Price - Sell
20 - 50 Day MACD Oscillator- Buy
20 Day Bollinger Bands - Hold

Short Term Indicators Average: 0% Hold
20-Day Average Volume - 7,228,750



Medium Term Indicators
40 Day Commodity Channel Index - Hold
50 Day Moving Average vs Price - Sell
20 - 100 Day MACD Oscillator- Buy
50 Day Parabolic Time/Price- Buy

Medium Term Indicators Average: 25% Buy
50-Day Average Volume - 6,894,454

Long Term Indicators
60 Day Commodity Channel Index - Hold
100 Day Moving Average vs Price- Buy
50 - 100 Day MACD Oscillator- Buy

Long Term Indicators Average: 67% Buy
100-Day Average Volume - 6,438,628

Overall Average: 16% Buy

Price - Support - Pivot Point - Resistance
7.91 7.78 7.91 8.04


Last Updated: Thursday, February 20, 2014 08:19:53 AM

ATML Stock Message Board and Forum http://investorshangout.com/search?q=ATML&...mp;yt0=Go!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

iBio's Fiscal Year 2024: Innovations and Financial Insights

Updated Category News Views 108

Overview of iBio’s Fiscal Year 2024 Financial Results iBio, Inc. (NYSEA:IBIO), a leader in biopharmaceuticals using AI technology, has recently shared its financial performance for the fiscal year that ended on June 30, 2024. The company is dedicated to developing antibody therapies for complex conditions, utilizing machine learning approaches to enhance their efforts....

Continue Reading
Atossa Therapeutics Ready to Present (Z)-Endoxifen Data Soon

Updated Category News Views 129

Exciting Developments for Atossa Therapeutics at Upcoming Symposium SEATTLE, November 2024 – Atossa Therapeutics, Inc. (NASDAQ: ATOS), a biopharmaceutical company known for its innovative approach in treating breast cancer, is gearing up to share groundbreaking research on (Z)-endoxifen at the upcoming San Antonio Breast Cancer Symposium (SABCS). This symposium is an...

Continue Reading
DraftKings Sportsbook Set to Debut at Live! Casino & Hotel

Updated Category News Views 100

Exciting Announcement for Sports Fans at Live! Casino & Hotel DraftKings is thrilled to announce its role as the official sportsbook for the highly anticipated Live! Casino & Hotel, which boasts a remarkable investment of over $270 million. This venue is set to create waves in the sports entertainment scene. The grand opening is expected, and it promises to be a game...

Continue Reading
Transforming Learning Spaces: A Milestone Celebration Ahead

Updated Category News Views 233

Transforming Learning Spaces with Collaborative Efforts In a remarkable initiative, School Specialty and the College Football Playoff Foundation are making strides in enhancing the educational landscape. Their recent accomplishment includes the makeover of a media center at North Dade Middle School, marking the 100th transformed learning environment as part of the Extra...

Continue Reading
Velvet Taco Innovates Menu with Exciting New Velvet Bowls

Updated Category News Views 481

Velvet Taco Introduces New Velvet Bowls to Excite Diners In an exciting move to shake up its menu, Velvet Taco proudly announces the launch of its latest creation, the Velvet Bowls. This fresh offering arrives after a successful "Weekly Bowl Feature" campaign that highlighted the restaurant's adventurous flavors without the need for tortillas. As a taco restaurant renown...

Continue Reading